grip of a pandemic that will claim many more lives than Ebola, because instead of being spread by contact like Ebola, it is spread by the bites of Aedes mosquitoes, the same ones that are spreading Angola`s population is about 24 million, and there is not enough vaccine available from manufacturers` stocks now, or that can be produced in the coming months with current capacity. Increasing production rapidly is problematic, since it can take up to six months to produce a batch of usable vaccine. Yellow fever vaccines can be stored for up to three years, but manufacturers can´t afford to over produce [3] . has not been stored at the correct temperature to ensure its potency, so it will be ineffective, and that it has been injected using a recycled syringe, risking transmission of hepatitis and HIV/AIDS, so that people who received stolen vaccine are not protected against YF.
YF undergoes cyclical re-emergence in its endemic habitat, where its reservoir is in monkeys and forest mosquitoes. In April an outbreak unrelated to that in Angola appeared in Uganda on the shore of Lake Victoria, unexpectedly far from the eastern edge of the equatorial forest. Sequencing has shown that the strain is of local origin, but it may portend more African outbreaks even beyond the YF endemic zone, with a need for yet more vaccine.
Three YF-infected Angolan travelers were reported on to have arrived in Kinshasa, Congo DR, with spread to one resident by 11
April (probably the tip of an iceberg), and both the government and WHO are warning that the epidemic could now spread there. It is hoped that the delay between notification and vaccination will not be as long as it was in Angola, with its disastrous results.
Other African countries currently considered as high risk yellow fever areas are; Benin, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Congo Republic, Ivory Coast, Equatorial Guinea, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Southern Sudan, Sudan, Togo and Uganda. Namibia and Zambia are requesting vaccine for prevention. But there will still be nowhere near enough. Existing coverage with YF vaccine is low in those few high risk countries which do vaccinate; Nigeria has only 50% coverage of its population, Angola only 18% coverage of its eligible 1-5-year-old children in 2014. Two independent studies published in 2013 showed that vaccine supplies, which are manufactured deliberately over-strength, can be expanded at least five-fold simply by giving a one-fifth dose, which affords full protection to adults [1] . This could be authorized as an emergency measure by the WHO Emergency Use Assessment and Listing procedure (EUAL). The manufacturers are trying hard to increase production --and vaccination production could be started or revived, for example in India, which used to produce it, if work is begun now --but it all takes time, and every day that passes without vaccination means YF will spread to more areas and more people will die.
We understand that WHO will consider the question of a five-fold expansion in June, during which another month`s supply of vaccine that could have been expanded five times will be irrevocably used Page number not for citation purposes 4 up. But surely the whole point of emergency measures is to immediately make exceptions to the routine approval process?
Mosquito control
Other emergency measures that could be implemented are mosquito control. Small fish that eat mosquito larvae are useful in cisterns and rainwater barrels, but not in small breeding sites such as plant axils, flower pots, animal watering containers, tires and trash left out in the rain. Use of transgenic mosquitoes, mosquito pathogens such as Bacillus thuringensis, Wohlbachia bacteria and hormones to attack the larvae of the urban mosquito will take too long to scale up and apply. Fogging with chemical pesticides provides temporary relief but does not affect eggs waiting to hatch and produce the next generation. There is a special oil for that.
Mycoinsecticides are of much lower toxicity than chemicals. 
Threat to Asia
On top of Africa`s immediate problems, an even worse scenario is unfolding in China. At least 11 cases of YF in Chinese construction workers and business people returning from Angola have arrived home for treatment, the first time in history that YF has been confirmed in Asia [7] . China has around 50 million people at risk in its dengue-endemic south once summer arrives; one province had 40,000 cases of dengue in a recent year [8] . If YF spreads to the megacities in the tropical dengue belt of Asia, where the YF mosquito is active year-round, it will be a tremendous disaster.
International donors should remember that a dollar spent on prevention at the source saves many times that amount in prevention and treatment at the donor`s home. This is, of course, provided the funds reach their intended target. Audits of international aid have shown problems with that elsewhere in Africa [9] .
Desperate situations demand desperate remedies. Vaccination coverage of 80% is needed to stop an epidemic. Let us hope use of a five-fold lower dose of vaccine can be implemented in time to stall this grave threat.
